ADDANTE, ELISABETTA Statistiche
ADDANTE, ELISABETTA
DIPARTIMENTO DI MEDICINA CLINICA E SPERIMENTALE
Mostra
records
Risultati 1 - 2 di 2 (tempo di esecuzione: 0.001 secondi).
The outcome of metastatic differentiated thyroid cancer is similar in patients prepared for 131-I therapy with recombinant TSH or Hypothyroidism.
2019-01-01 Campopiano, Mc; Podestà, D; Addante, E; Giani, C; Bianchi, F; Agate, L; Viola, D; Elisei, R; Molinaro, E.
Impact of the Stimulation method Used for 131-Therapy in Patients With Differentiated Thyroid Cancer.
2018-01-01 Addante, E; Giani, C; Bianchi, F; Brozzi, F; Santini, P; Agate, L; Viola, D; Bottici, V; Vitti, P; Elisei, E; Molinaro, E.
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
The outcome of metastatic differentiated thyroid cancer is similar in patients prepared for 131-I therapy with recombinant TSH or Hypothyroidism. | 1-gen-2019 | Campopiano, Mc; Podestà, D; Addante, E; Giani, C; Bianchi, F; Agate, L; Viola, D; Elisei, R; Molinaro, E. | |
Impact of the Stimulation method Used for 131-Therapy in Patients With Differentiated Thyroid Cancer. | 1-gen-2018 | Addante, E; Giani, C; Bianchi, F; Brozzi, F; Santini, P; Agate, L; Viola, D; Bottici, V; Vitti, P; Elisei, E; Molinaro, E. |